Literature DB >> 22233432

Disruptions in the regulation of extracellular glutamate by neurons and glia in the rat striatum two days after diffuse brain injury.

Jason M Hinzman1, Theresa Currier Thomas, Jorge E Quintero, Greg A Gerhardt, Jonathan Lifshitz.   

Abstract

Disrupted regulation of extracellular glutamate in the central nervous system contributes to and can exacerbate the acute pathophysiology of traumatic brain injury (TBI). Previously, we reported increased extracellular glutamate in the striatum of anesthetized rats 2 days after diffuse brain injury. To determine the mechanism(s) responsible for increased extracellular glutamate, we used enzyme-based microelectrode arrays (MEAs) coupled with specific pharmacological agents targeted at in vivo neuronal and glial regulation of extracellular glutamate. After TBI, extracellular glutamate was significantly increased in the striatum by (∼90%) averaging 4.1±0.6 μM compared with sham 2.2±0.4 μM. Calcium-dependent neuronal glutamate release, investigated by local application of an N-type calcium channel blocker, was no longer a significant source of extracellular glutamate after TBI, compared with sham. In brain-injured animals, inhibition of glutamate uptake with local application of an excitatory amino acid transporter inhibitor produced significantly greater increase in glutamate spillover (∼ 65%) from the synapses compared with sham. Furthermore, glutamate clearance measured by locally applying glutamate into the extracellular space revealed significant reductions in glutamate clearance parameters in brain-injured animals compared with sham. Taken together, these data indicate that disruptions in calcium-mediated glutamate release and glial regulation of extracellular glutamate contribute to increased extracellular glutamate in the striatum 2 days after diffuse brain injury. Overall, these data suggest that therapeutic strategies used to regulate glutamate release and uptake may improve excitatory circuit function and, possibly, outcomes following TBI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22233432      PMCID: PMC3325551          DOI: 10.1089/neu.2011.2261

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  86 in total

1.  The effect of MK-801 on extracellular neuroactive amino acids in hippocampus after closed head injury followed by hypoxia in rats.

Authors:  H Katoh; K Sima; H Nawashiro; K Wada; H Chigasaki
Journal:  Brain Res       Date:  1997-05-30       Impact factor: 3.252

Review 2.  Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity.

Authors:  S Nakanishi
Journal:  Neuron       Date:  1994-11       Impact factor: 17.173

3.  Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

Authors:  J D Rothstein; M Dykes-Hoberg; C A Pardo; L A Bristol; L Jin; R W Kuncl; Y Kanai; M A Hediger; Y Wang; J P Schielke; D F Welty
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

4.  Role of extracellular glutamate measured by cerebral microdialysis in severe traumatic brain injury.

Authors:  Roukoz Chamoun; Dima Suki; Shankar P Gopinath; J Clay Goodman; Claudia Robertson
Journal:  J Neurosurg       Date:  2010-09       Impact factor: 5.115

5.  Antisense knockdown of the glial glutamate transporter GLT-1 exacerbates hippocampal neuronal damage following traumatic injury to rat brain.

Authors:  V L Rao; A Dogan; K K Bowen; K G Todd; R J Dempsey
Journal:  Eur J Neurosci       Date:  2001-01       Impact factor: 3.386

6.  Voltammetric study of extracellular dopamine near microdialysis probes acutely implanted in the striatum of the anesthetized rat.

Authors:  Laura M Borland; Guoyue Shi; Hua Yang; Adrian C Michael
Journal:  J Neurosci Methods       Date:  2005-03-05       Impact factor: 2.390

7.  LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia.

Authors:  A Bond; N Ragumoorthy; J A Monn; C A Hicks; M A Ward; D Lodge; M J O'Neill
Journal:  Neurosci Lett       Date:  1999-10-08       Impact factor: 3.046

8.  Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model.

Authors:  A M Palmer; D W Marion; M L Botscheller; P E Swedlow; S D Styren; S T DeKosky
Journal:  J Neurochem       Date:  1993-12       Impact factor: 5.372

9.  Traumatic brain injury causes a long-lasting calcium (Ca2+)-plateau of elevated intracellular Ca levels and altered Ca2+ homeostatic mechanisms in hippocampal neurons surviving brain injury.

Authors:  David A Sun; Laxmikant S Deshpande; Sompong Sombati; Anya Baranova; Margaret S Wilson; Robert J Hamm; Robert J DeLorenzo
Journal:  Eur J Neurosci       Date:  2008-03-25       Impact factor: 3.386

10.  Targeted over-expression of glutamate transporter 1 (GLT-1) reduces ischemic brain injury in a rat model of stroke.

Authors:  Brandon K Harvey; Mikko Airavaara; Jason Hinzman; Emily M Wires; Matthew J Chiocco; Douglas B Howard; Hui Shen; Greg Gerhardt; Barry J Hoffer; Yun Wang
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

View more
  38 in total

1.  Aberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.

Authors:  Erin M Miller; Francois Pomerleau; Peter Huettl; Greg A Gerhardt; Paul E A Glaser
Journal:  Psychopharmacology (Berl)       Date:  2014-02-28       Impact factor: 4.530

2.  Glutaraldehyde cross-linked glutamate oxidase coated microelectrode arrays: selectivity and resting levels of glutamate in the CNS.

Authors:  Jason J Burmeister; Verda A Davis; Jorge E Quintero; Francois Pomerleau; Peter Huettl; Greg A Gerhardt
Journal:  ACS Chem Neurosci       Date:  2013-05-09       Impact factor: 4.418

Review 3.  Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better?

Authors:  Anthony E Kline; Jacob B Leary; Hannah L Radabaugh; Jeffrey P Cheng; Corina O Bondi
Journal:  Prog Neurobiol       Date:  2016-05-07       Impact factor: 11.685

4.  Acute treatment with doxorubicin affects glutamate neurotransmission in the mouse frontal cortex and hippocampus.

Authors:  Theresa Currier Thomas; Joshua A Beitchman; Francois Pomerleau; Teresa Noel; Paiboon Jungsuwadee; D Allan Butterfield; Daret K St Clair; Mary Vore; Greg A Gerhardt
Journal:  Brain Res       Date:  2017-07-11       Impact factor: 3.252

5.  Lithium increases hippocampal SNARE protein abundance after traumatic brain injury.

Authors:  Shaun W Carlson; Hong Yan; C Edward Dixon
Journal:  Exp Neurol       Date:  2016-12-21       Impact factor: 5.330

6.  Real-time monitoring of extracellular adenosine using enzyme-linked microelectrode arrays.

Authors:  Jason M Hinzman; Justin L Gibson; Ryan D Tackla; Mark S Costello; Jason J Burmeister; Jorge E Quintero; Greg A Gerhardt; Jed A Hartings
Journal:  Biosens Bioelectron       Date:  2015-07-07       Impact factor: 10.618

7.  Blast wave exposure impairs memory and decreases axon initial segment length.

Authors:  Kelli L Baalman; R James Cotton; S Neil Rasband; Matthew N Rasband
Journal:  J Neurotrauma       Date:  2013-02-06       Impact factor: 5.269

8.  Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models.

Authors:  Holly C Hunsberger; Sharay E Setti; Ryan T Heslin; Jorge E Quintero; Greg A Gerhardt; Miranda N Reed
Journal:  J Vis Exp       Date:  2017-05-03       Impact factor: 1.355

9.  Astrocytic glutamate uptake is slow and does not limit neuronal NMDA receptor activation in the neonatal neocortex.

Authors:  Elizabeth Hanson; Moritz Armbruster; David Cantu; Lauren Andresen; Amaro Taylor; Niels Christian Danbolt; Chris G Dulla
Journal:  Glia       Date:  2015-04-27       Impact factor: 7.452

10.  Experimental traumatic brain injury alters ethanol consumption and sensitivity.

Authors:  Jennifer L Lowing; Laura L Susick; James P Caruso; Anthony M Provenzano; Ramesh Raghupathi; Alana C Conti
Journal:  J Neurotrauma       Date:  2014-09-02       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.